Longitudinal Trajectories in Cortical Thickness and Volume Atrophy: Superior Cognitive Performance Does Not Protect Against Brain Atrophy in Older Adults.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2021
Historique:
pubmed: 4 5 2021
medline: 18 9 2021
entrez: 3 5 2021
Statut: ppublish

Résumé

Previous research has identified a small subgroup of older adults that maintain a high level of cognitive functioning well into advanced age. Investigation of those with superior cognitive performance (SCP) for their age is important, as age-related decline has previously been thought to be inevitable. Preservation of cortical thickness and volume was evaluated in 76 older adults with SCP and 100 typical older adults (TOAs) assessed up to five times over six years. Regions of interest (ROIs) found to have been associated with super-aging status (a construct similar to SCP status) in previous literature were investigated, followed by a discovery phase analyses of additional regions. SCPs were aged 70 + at baseline, scoring at/above normative memory (CVLT-II) levels for demographically similar individuals aged 30-44 years old, and in the unimpaired range for all other cognitive domains over the course of the study. In linear mixed models, following adjustment for multiple comparisons, there were no significant differences between rates of thinning or volume atrophy between SCPs and TOAs in previously identified ROIs, or the discovery phase analyses. With only amyloid-β negative individuals in the analyses, again there were no significant differences between SCPs and TOAs. The increased methodological rigor in classifying groups, together with the influence of cognitive reserve, are discussed as potential factors accounting for our findings as compared to the extant literature on those with superior cognitive performance for their age.

Sections du résumé

BACKGROUND
Previous research has identified a small subgroup of older adults that maintain a high level of cognitive functioning well into advanced age. Investigation of those with superior cognitive performance (SCP) for their age is important, as age-related decline has previously been thought to be inevitable.
OBJECTIVE
Preservation of cortical thickness and volume was evaluated in 76 older adults with SCP and 100 typical older adults (TOAs) assessed up to five times over six years.
METHODS
Regions of interest (ROIs) found to have been associated with super-aging status (a construct similar to SCP status) in previous literature were investigated, followed by a discovery phase analyses of additional regions. SCPs were aged 70 + at baseline, scoring at/above normative memory (CVLT-II) levels for demographically similar individuals aged 30-44 years old, and in the unimpaired range for all other cognitive domains over the course of the study.
RESULTS
In linear mixed models, following adjustment for multiple comparisons, there were no significant differences between rates of thinning or volume atrophy between SCPs and TOAs in previously identified ROIs, or the discovery phase analyses. With only amyloid-β negative individuals in the analyses, again there were no significant differences between SCPs and TOAs.
CONCLUSION
The increased methodological rigor in classifying groups, together with the influence of cognitive reserve, are discussed as potential factors accounting for our findings as compared to the extant literature on those with superior cognitive performance for their age.

Identifiants

pubmed: 33935071
pii: JAD201243
doi: 10.3233/JAD-201243
pmc: PMC8293653
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1039-1052

Références

JAMA. 2017 Apr 4;317(13):1373-1375
pubmed: 28384819
Neurobiol Aging. 2010 Aug;31(8):1275-83
pubmed: 20472326
Neuroimage. 2012 Jul 16;61(4):1402-18
pubmed: 22430496
Brain. 2009 Dec;132(Pt 12):3411-27
pubmed: 19942676
J Neurosci. 2009 Dec 2;29(48):15223-31
pubmed: 19955375
J Int Neuropsychol Soc. 2002 Mar;8(3):448-60
pubmed: 11939702
J Neurosci. 2016 Apr 20;36(16):4600-13
pubmed: 27098701
J Cogn Neurosci. 2013 Jan;25(1):29-36
pubmed: 23198888
Brain. 2010 Aug;133(Pt 8):2196-209
pubmed: 20591858
Nat Commun. 2017 Mar 24;8:14823
pubmed: 28337990
Neuroimage. 2012 Aug 15;62(2):774-81
pubmed: 22248573
J Neurosci. 2015 Jan 28;35(4):1781-91
pubmed: 25632151
Neuroimage. 2006 Feb 1;29(3):984-94
pubmed: 16176876
Brain Topogr. 2011 Oct;24(3-4):279-91
pubmed: 21842406
Clin Neuropsychol. 2000 Nov;14(4):526-34
pubmed: 11262721
Neuroimage. 2013 Aug 1;76:332-44
pubmed: 23507382
Neurobiol Aging. 2015 Jan;36 Suppl 1:S159-66
pubmed: 25257985
Neuroimage. 2018 May 1;171:62-74
pubmed: 29277646
Neurobiol Aging. 2018 Jul;67:162-170
pubmed: 29665578
Alzheimers Dement (Amst). 2019 Aug 12;11:566-575
pubmed: 31909172
Hippocampus. 2019 May;29(5):458-467
pubmed: 29341318
J Int Neuropsychol Soc. 2012 Nov;18(6):1081-5
pubmed: 23158231
J Neurosci. 2016 Sep 14;36(37):9659-68
pubmed: 27629716
Ann Neurol. 2013 Dec;74(6):905-13
pubmed: 24448836
Int Psychogeriatr. 2009 Aug;21(4):672-87
pubmed: 19470201
Cereb Cortex. 2004 Jul;14(7):721-30
pubmed: 15054051
Neuropsychologia. 2011 Jul;49(9):2384-90
pubmed: 21529702
Alzheimers Dement (Amst). 2019 Aug 12;11:560-561
pubmed: 31909169

Auteurs

Samantha L Gardener (SL)

Centre of Excellence for Alzheimer's Disease Research & Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
Australian Alzheimer's Research Foundation, Perth, Western Australia, Australia.

Michael Weinborn (M)

Centre of Excellence for Alzheimer's Disease Research & Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
Australian Alzheimer's Research Foundation, Perth, Western Australia, Australia.
School of Psychological Science, University of Western Australia, Crawley, Western Australia, Australia.

Hamid R Sohrabi (HR)

Centre of Excellence for Alzheimer's Disease Research & Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
Australian Alzheimer's Research Foundation, Perth, Western Australia, Australia.
College of Science, Health, Engineering and Education, Murdoch University, Murdoch, Western Australia, Australia.
Department of Biomedical Sciences, Macquarie University, New South Wales, Australia.

James D Doecke (JD)

CSIRO Health and Biosecurity/Australian eHealth Research Centre, Herston, Queensland, Australia.

Pierrick Bourgeat (P)

CSIRO Health and Biosecurity/Australian eHealth Research Centre, Herston, Queensland, Australia.

Stephanie R Rainey-Smith (SR)

Centre of Excellence for Alzheimer's Disease Research & Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
Australian Alzheimer's Research Foundation, Perth, Western Australia, Australia.
School of Psychological Science, University of Western Australia, Crawley, Western Australia, Australia.
Centre for Healthy Ageing, Health Futures Institute, Murdoch University, Murdoch, Western Australia, Australia.

Kai-Kai Shen (KK)

Centre of Excellence for Alzheimer's Disease Research & Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
Australian Alzheimer's Research Foundation, Perth, Western Australia, Australia.
CSIRO Health and Biosecurity/Australian eHealth Research Centre, Herston, Queensland, Australia.

Jurgen Fripp (J)

CSIRO Health and Biosecurity/Australian eHealth Research Centre, Herston, Queensland, Australia.

Kevin Taddei (K)

Centre of Excellence for Alzheimer's Disease Research & Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
Australian Alzheimer's Research Foundation, Perth, Western Australia, Australia.

Paul Maruff (P)

CogState, Ltd., Melbourne, Victoria, Australia.

Olivier Salvado (O)

CSIRO Health and Biosecurity/Australian eHealth Research Centre, Herston, Queensland, Australia.
CSIRO Data61, Sydney, Australia.

Greg Savage (G)

ARC Centre of Excellence in Cognition and its Disorders and Department of Psychology, Macquarie University, New South Wales, Australia.

David Ames (D)

National Ageing Research Institute, Royal Melbourne Hospital, Melbourne, Australia.
Academic Unit for Psychiatry of Old Age, University of Melbourne, Melbourne, Australia.

Colin L Masters (CL)

The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia.

Christopher C Rowe (CC)

Department of Molecular Imaging and Therapy, Centre for PET, Austin Health, Heidelberg, Victoria, Australia.
Florey Department of the University of Melbourne.

Ralph N Martins (RN)

Centre of Excellence for Alzheimer's Disease Research & Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
Australian Alzheimer's Research Foundation, Perth, Western Australia, Australia.
Department of Biomedical Sciences, Macquarie University, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH